Eli Lilly & Co. halted a study of an experimental drug designed to prevent obesity patients from losing too much muscle, citing strategic business reasons it didn’t disclose. Lilly closed the trial on ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Eli Lilly's CEO reveals the ...

Eli Lilly's shares have increased by about 10% over the past month. Clinical progress in the past few weeks has helped solidify its lead in the weight loss market. The company's prospects remain ...

Sept 25 (Reuters) - Eli Lilly (LLY.N), opens new tab has halted a study of an experimental drug, designed to prevent obesity patients from losing too much muscle, due to strategic business reasons, ...

Most effective drugs for obesity and its complications are semaglutide, tirzepatide, new European guideline says Certain GLP-1 drugs are best for specific complications The non-binding guideline ...

Corey Dambacher was working in Oregon when he discovered a type of ribonucleic acid capable of creating unique types of proteins that express themselves on the surfaces of cancer cells. It’s just the ...

Eli Lilly and Company plans to invest $6.5 billion to build a manufacturing facility at Generation Park in Houston, Texas. The new site will produce active pharmaceutical ingredients (APIs) for small ...

Pharmaceutical giant Eli Lilly unveiled plans to build a $6.5 billion biomanufacturing plant in northeast Houston within the next five years, bolstering the region’s bid to become a national ...

President Donald Trump announced on Sept. 25 that the U.S. will impose a 100% tariff on branded or patented pharmaceutical products that enter the country starting Oct 1. But Eli Lilly, one of ...

Want to catch all the action of Dancing with the Stars Season 34? Our DWTS superfans have put together the ultimate guide to streaming the show online without a cable subscription. Read on and get ...

Eli Lilly And Company (NYSE:LLY) shares are trading higher Wednesday after President Donald Trump recently announced a deal with Pfizer as well as the ‘TrumpRx’ site to decrease prices. What To Know: ...

Eli Lilly’s valuation has compressed significantly from last year’s highs, despite fundamentals improving faster than its share price. Industry-leading incretin treatments (Mounjaro, Zepbound) are ...